Brief: BIOSYNEX Confirms FY Revenue Target

Biosynex SA

11/01/2021 17:11

Jan 11 (Reuters) - Biosynex SA  ALBIO.PA :
    * ANTICIPATES THE CONTINUATION OF THE RIGHT ORIENTATION OF
ITS
COMMERCIAL ACTIVITY IN THE FIRST HALF OF 2021
    * CONFIRMS ITS 2020 TURNOVER TARGET OF OVER € 150 MILLION
    * GOT AUTHORIZATION FROM THE FEDERAL PUBLIC HEALTH OFFICE OF
SWITZERLAND FOR ITS ANTIGENIC COVID-19 TESTS
    * FULL CONFIDENCE FOR ITS FY 2021

Source text for Eikon:  ID:nBw7g0lnla 
Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))